Charles Rosier is the CEO and Co- Founder of Augustinus Bader. Prior to that he was a Managing Director at Goldman Sachs and an investor in Biotechnology. Charles Rosier chose to apply his financial background and network to become involved in investments that would contribute to research solutions for medical conditions as well as environmental and humanitarian causes. His most recent investment endeavor includes a joint business venture with Augustinus Bader, a prominent German professor who has conducted studies involving regenerative medicine and stem cell research for the past three decades. In 2007, Bader constituted a hydrogel utilizing revolutionary stem cell science that eliminates the need for skin grafts, scar revision and minimizes opportunistic infections that can create a circle of trauma for burn victims. Realizing the potential of this breakthrough, Rosier partnered with Professor Bader to form the Bader Group, a business model structured around maximizing biomedical research and biotechnological treatments across a broad spectrum of interventions and diseases.